These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 21288184)

  • 1. Pharmacotherapy for overactive bladder: minimally invasive treatment -- botulinum toxins.
    Apostolidis A
    Expert Opin Pharmacother; 2011 May; 12(7):1029-39. PubMed ID: 21288184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB).
    Cruz F; Nitti V
    Neurourol Urodyn; 2014 Jul; 33 Suppl 3():S26-31. PubMed ID: 25042140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects and limitations of treatment with botulinum neurotoxin type A for patients with refractory idiopathic detrusor overactivity.
    Schmid DM; Roy S; Sulser T; Scheiner D
    BJU Int; 2008 Jul; 102 Suppl 1():7-10. PubMed ID: 18665972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin injections for adults with overactive bladder syndrome.
    Duthie JB; Vincent M; Herbison GP; Wilson DI; Wilson D
    Cochrane Database Syst Rev; 2011 Dec; (12):CD005493. PubMed ID: 22161392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin treatment for bladder dysfunction.
    Santos-Silva A; da Silva CM; Cruz F
    Int J Urol; 2013 Oct; 20(10):956-62. PubMed ID: 23634720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chapter 4: Guidelines for the diagnosis and treatment of overactive bladder (OAB) and neurogenic detrusor overactivity (NDO).
    Nambiar A; Lucas M
    Neurourol Urodyn; 2014 Jul; 33 Suppl 3():S21-5. PubMed ID: 25042139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely.
    Prescrire Int; 2013 Jan; 22(134):12-3. PubMed ID: 23367677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of intravesical botulinum toxin therapy in idiopathic detrusor overactivity.
    Patel AK; Patterson JM; Chapple CR
    Int J Clin Pract Suppl; 2006 Dec; (151):27-32. PubMed ID: 17169008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity.
    Sussman D; Patel V; Del Popolo G; Lam W; Globe D; Pommerville P
    Neurourol Urodyn; 2013 Mar; 32(3):242-9. PubMed ID: 22965657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based review and assessment of botulinum neurotoxin for the treatment of urologic conditions.
    Chancellor MB; Elovic E; Esquenazi A; Naumann M; Segal KR; Schiavo G; Smith CP; Ward AB
    Toxicon; 2013 Jun; 67():129-40. PubMed ID: 23415704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events of intravesical botulinum toxin a injections for idiopathic detrusor overactivity: risk factors and influence on treatment outcome.
    Kuo HC; Liao CH; Chung SD
    Eur Urol; 2010 Dec; 58(6):919-26. PubMed ID: 20864251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin A for the Treatment of Overactive Bladder.
    Hsieh PF; Chiu HC; Chen KC; Chang CH; Chou EC
    Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26938559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder.
    Rovner E; Kennelly M; Schulte-Baukloh H; Zhou J; Haag-Molkenteller C; Dasgupta P
    Neurourol Urodyn; 2011 Apr; 30(4):556-62. PubMed ID: 21351127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin injections for adults with overactive bladder syndrome.
    Duthie J; Wilson DI; Herbison GP; Wilson D
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005493. PubMed ID: 17636801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of Action of Botulinum Toxin A in Treatment of Functional Urological Disorders.
    Lin YH; Chiang BJ; Liao CH
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32085522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of urinary tract infection after detrusor botulinum toxin A injections for refractory neurogenic detrusor overactivity in patients with no antibiotic treatment.
    Mouttalib S; Khan S; Castel-Lacanal E; Guillotreau J; De Boissezon X; Malavaud B; Marque P; Rischmann P; Gamé X
    BJU Int; 2010 Dec; 106(11):1677-80. PubMed ID: 20590550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin a versus placebo for refractory detrusor overactivity in women: a randomised blinded placebo-controlled trial of 240 women (the RELAX study).
    Tincello DG; Kenyon S; Abrams KR; Mayne C; Toozs-Hobson P; Taylor D; Slack M
    Eur Urol; 2012 Sep; 62(3):507-14. PubMed ID: 22236796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technical aspects of botulinum toxin type A injection in the bladder to treat urinary incontinence: reviewing the procedure.
    Karsenty G; Baverstock R; Carlson K; Diaz DC; Cruz F; Dmochowski R; Fulford S; Giannantoni A; Heesakkers J; Kaufmann A; Peyrat L; Thavaseelan J; Dasgupta P
    Int J Clin Pract; 2014 Jun; 68(6):731-42. PubMed ID: 24472109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder base/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinics.
    Kuo HC
    Neurourol Urodyn; 2011 Sep; 30(7):1242-8. PubMed ID: 21560152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury.
    Mehta S; Hill D; McIntyre A; Foley N; Hsieh J; Ethans K; Teasell RW; Loh E; Welk B; Wolfe D
    Arch Phys Med Rehabil; 2013 Aug; 94(8):1473-81. PubMed ID: 23632286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.